Stay updated on 24H Alteplase in Ischemic Stroke Clinical Trial
Sign up to get notified when there's something new on the 24H Alteplase in Ischemic Stroke Clinical Trial page.

Latest updates to the 24H Alteplase in Ischemic Stroke Clinical Trial page
- CheckyesterdayChange DetectedThe footer now identifies the site as revision v3.8.0 instead of v3.7.2. The page still displays a 403 Forbidden error rather than the study record.SummaryDifference0.2%

- Check7 days agoChange DetectedA banner announces an NIH website transition and says agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) during the transition.SummaryDifference1%

- Check14 days agoChange DetectedThe ClinicalTrials.gov error page footer shows an updated site revision, from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check21 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check42 days agoChange DetectedA 403 Forbidden error page is now shown for the study record, replacing the previous content and navigation with a standard error page. This makes the study details temporarily inaccessible on that URL.SummaryDifference17%

- Check63 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, representing a new revision of the ClinicalTrials.gov entry. This update likely includes small backend or formatting adjustments without altering the study details.SummaryDifference0.1%

Stay in the know with updates to 24H Alteplase in Ischemic Stroke Clinical Trial
Enter your email address, and we'll notify you when there's something new on the 24H Alteplase in Ischemic Stroke Clinical Trial page.